Kclavis
VC Fund
Kclavis is a VC fund focused on Biotechnology and Pharmaceutical. Kclavis pursues a stable return on customer assets. It provides technology-driven companies with investments and asset management services. The company was founded in 2013 and is headquartered in Seoul.
- Total investments:
- 20
- Last investment:
- Lead investor:
- 5%
Last updated:
For AI agents: llms.txt
Industries Kclavis invests in
Stages Kclavis invests in
Countries Kclavis invests in
Round sizes
Round size
- Seed
- $892k–$3M
- Series A
- $2.8M–$18M
- Series B
- $7.9M–$27M
Investment Focus
Industry
- Biotechnology 7 (35%)
- Pharmaceutical 4 (20%)
- Financial Services 3 (15%)
- FinTech 2 (10%)
- Biopharma 2 (10%)
Stage
- Series A 6 (30%)
- Seed 3 (15%)
- Series B 3 (15%)
- Series C 3 (15%)
- Funding Round 2 (10%)
Country
- South Korea 17 (85%)
- United States 1 (5%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Daishin Value REIT is a real estate investment trust within the financial sector. The firm manages a portfolio of commercial real estate properties. The organization utilizes a fund-of-funds structural model for its specific investment activities. The public parent trust holds all equity shares in a privately placed subordinate trust. Thissubordinate entity directly owns and controls the physical office buildings. | $138.4M / Mar 27, 2025 | ||
R&R Lab
|
R&R Lab is a semiconductor manufacturing startup that develops heat treatment equipment. | $2.1M / Venture - Series Unknown / Mar 15, 2024 | |
Nuon Media
|
Nuon Media is an Internet e-book store that sells famous domestic romance martial arts fantasy fantasy novels. | $2.8M / Series A / Oct 12, 2022 | |
| Inkle is a technology company specializing in industrial data platforms optimized for manufacturing environments. Their product, Nazare, is a machinery data platform designed to collect, store, transform, and analyze vast amounts of real-time data from industrial machinery. They provide solutions for businesses to enhance utilization, quality, andyield by real-time data insights. | $2.5M / Seed / Jul 12, 2022 | ||
| HANDHUG is a content commercialization company. | $6.1M / Series A / May 17, 2022 | ||
| Selecxine is a biopharmaceutical development company specialized in the field of immunotherapeutics. Selecxine strives to develop immunotherapeutics a new paradigm of pharmaceuticals– through a specialized antibody development process, using an innovative platform technology of functional antibody screening and development. | $27.3M / Series B / Mar 29, 2022 | ||
| Iron Device is a fabless semiconductor company specializing in mixed-signal System-on-Chip (SoC) solutions that integrate digital, analog, and power components. The company offers audio amplifiers and codecs for applications in mobile devices, smart speakers, automotive systems, and high-power audio equipment. Their product lineup includes displaysound amplifiers, HiFi headphone amplifiers, AI/BT speaker modules, and super power amplifiers up to 4kW. | $3.4M / Series A / Jan 01, 2022 | ||
| Korea Credit Data provides essential services for merchants in Korea including business management, customer analysis, POS and payment services as well as marketplace platform. KCD and its six subsidiaries currently serve more than two million businesses in Korea. KCD aims to resolve issues a business owner faces from the beginning to end of hisbusiness life. To this end, KCD expands its business areas to include payment(Korea Payment Networks), POS(IMU), and credit bureau(Korea Credit Service) which obtained a CB license for the first time in 17 years.KCD made strong strategic partnerships with industry leading companies and built a high entry barrier; the company raised $220M+ from Temasek(Pavilion Capital), Morgan Stanley(Tactical Value), Kakao(No.1 mobile platform in Korea), KB Kookmin Bank(No.1 retail bank in Korea), Hanwha Life Insurance, Shinhan Card(No.1 credit card company in Korea), Dunamu(No.1 cryptocurrency exchange in Korea 'Upbit'), GS Holdings(No.1 CVS in Korea 'GS25'), Fiserv(the largest non-bank merchant acquirer) and more. | $28.1M / Series D / Nov 17, 2021 | ||
| StradVision offers an embedded perception algorithm designed for advanced driver assistance systems and applications in autonomous vehicles. Utilizing its production-ready ADAS software IP platform, which employs camera-based perception AI or LiDAR, StradVision is committed to its roadmap towards achieving autonomous driving. The machine learningalgorithm developed by StradVision has attained the top performance in prestigious technological evaluations, including scene text detection in both English and Chinese, as well as pedestrian detection. StradVision's computer vision algorithm is both precise and rapid, operating seamlessly on embedded and IoT devices. | $33.4M / Series C / Oct 09, 2021 | ||
| BeyondBio is a biotechnology firm that specializes in the research and development of synthetic pharmaceutical drugs. | $13.6M / Venture - Series Unknown / Aug 22, 2021 | ||
| See all 20 investments → | |||
Co-Investors
KB Securities
3 deals together
Shinhan Capital
3 deals together
Smilegate Investment
3 deals together
BNH Investment
2 deals together
Dreamstone Partners
2 deals together
FOCUS ASSET MANAGEMENT
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Kclavis invest in?
Kclavis invests primarily in Biotechnology, Pharmaceutical and Financial Services startups, most often at Series A and Seed stage. Most of the 20 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Kclavis's check size?
Kclavis typically joins rounds of $892k–$3M at Seed, $2.8M–$18M at Series A and $7.9M–$27M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Kclavis participates in.
When did Kclavis last invest?
The most recent investment recorded for Kclavis closed in Mar 2025. Shizune tracks 20 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
